We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Innovative marketplace platform that is disrupting the rapidly digitizing global outdoor media market.
days to go: Expired investment: £739,406
AVATR is an AI mobile application designed to deliver social, economic and health benefits. It enables patients to create a digital profile for themselves and share it with their doctor to avail convenient medical care outside of the hospitals. AVATR is negotiating a collaboration agreement in Brazil with Incor Heart Institute and Albert Einstein Institute at the Hospital das Clínicas da Universidade de São Paulo. Moreover, it has been featured in Forbes and has earned recognition in Europe, South America and Asia. With the funds raised, AVATR is planning to be introduced to a number of paying patients in Singapore within the first quarters of 2019.
days to go: Expired investment: £279,821
Aguulp innovates and curates liquid formulas using liposomal technology. The company asserts that vitamins in pill form have an absorption rate as low as 5% which is further eaten by stomach acid upon consumption before a person gets a chance to absorb it. Agullp aims to resolve this. Its product, NutriProtect, shields nutrients from corrosive stomach acid and helps 98% of nutrients reach the small intestine for absorption. The company estimates that over 3 million people in the UK and more than 10 per cent of the world’s population is malnourished for a variety of reasons, including environmental pollution, unhealthy diets and stressful lifestyles that block nutrient absorption and compound deficiencies. Aguulp aims to change this with its product line that includes Aguulp for Gut, Aguulp for Brain, and Aguulp for Immunity. The company will use 55.6% of the investment for marketing purposes, 44.2% for paying their staff, and 0.2% as other expenses.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £317,993
Small Robot Company (SRC) aims to integrate its patented 'PerPlant' farming with agricultural practices worldwide and disrupt the $240 billion per year agriculture industry. SRC claims that PerPlant farming uses lightweight and smart robots that make food production more accurate, sustainable and profitable. SRC's three small robots, 'Tom', 'Dick' and 'Harry' coupled with AI brain 'Wilma' can plant, monitor and treat arable crops autonomously. SRC argues that it has successfully commercialised its PerPlant monitoring service for farmers in Wiltshire using its 'Tom V3' robots, built by leading robotics manufacturer, Tharsus. SRC stresses that it will equip its robots to kill weeds autonomously using electricity and perform trials with customers next season to demonstrate product readiness. SRC points out that it has raised more than £400,000 from willing farmers who want to embrace change. SRC has featured in WIRED, Economist and CNN. It has onboarded customers, including Waitrose and National Trust. SRC state they will use the investment to commercialise its patented R&D.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £3,996,978
Little Earth Baby is an eco brand offering a range of baby products that are synthetic-free and natural. It aims to become a global market leader in the eco baby space by redesigning synthetic products to develop high-quality alternatives made from plants, not plastic. With the patent-pending designs and a growing loyal customer base, the company is well-placed to serve rising eco-conscious consumer trends. Additionally, Little Earth Baby appeared in the Telegraph's recommendations for Meghan & Harry's royal baby. The company also became a finalist in the Sleeping Bag category at the Australian non-toxic awards. 

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £147,010
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go: Expired investment: £182,281
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £200,000
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics. Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
days to go: Expired investment: £250,000
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go: Expired investment: £62,770
innerworks is a behavioural analysis technology company that aims to capture and verify the true nature of people to build happier and more productive workforces. innerworks crowdsources anonymous opinions about people over time. The company argues that this verification model leverages objective, credible data, making its profiles more unique. Its mission is to empower users with their behavioural data. The company is backed by Ex-Microsoft and Ex-Groupon managers as part of this crwodfunding round. It has been featured in TechRound and Startups Magazine. innerworks will use the investment to finance product development and initial client traction ahead of its Q3 2021 seed round.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £231,386
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph